— Know what they know.
Not Investment Advice
Also trades as: 0K05.L (LSE) · $vol 0M

MED NYSE

Medifast, Inc.
1W: +0.6% 1M: +15.6% 3M: +19.1% YTD: +21.7% 1Y: -9.2% 3Y: -85.3% 5Y: -95.2%
$12.59
-0.04 (-0.32%)
After Hours: $12.95 (+0.36, +2.86%)
Weekly Expected Move ±11.8%
$10 $11 $13 $14 $15
NYSE · Consumer Cyclical · Personal Products & Services · Alpha Radar Strong Buy · Power 68 · $140.0M mcap · 8M float · 2.83% daily turnover · Short 62% of daily vol

Cash Flow Trends

Operating Cash Flow
$7M -72.0% ▼
5Y CAGR: -45.7%
Capital Expenditures
$6M +24.7% ▲
5Y CAGR: -0.9%
Free Cash Flow
$1M -92.7% ▼
5Y CAGR: -61.0%
Dividends Paid
$195K +72.7% ▲
Buybacks
$369K +55.9% ▲
Net Change in Cash
-$2M +53.7% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$164M$144M$99M$2M-$19M
Depreciation & Amort.$7M$11M$13M$17M$14M
Stock-Based Comp.$10M$11M$8M$7M$8M
Change in Working Capital-$88M$22M$20M-$10M-$10M
Other Non-Cash Items$5M$8M$5M$15M$2M
Operating Cash Flow$95M$195M$148M$24M$7M
— Investing Activities —
Capital Expenditures-$34M-$17M-$6M-$7M-$6M
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0-$55M-$47M-$84M
Investment Sales$5M$5M$0$27M$79M
Other Investing$0$0$0$95K$3M
Investing Cash Flow-$29M-$11M-$61M-$27M-$8M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased-$62M-$128M-$7M-$836K-$369K
Dividends Paid-$64M-$72M-$73M-$715K-$195K
Other Financing$811K$0$188K$36K$0
Financing Cash Flow-$125M-$200M-$80M-$2M-$564K
Net Change in Cash-$60M-$16M$7M-$4M-$2M
Cash End of Period$104M$88M$94M$91M$89M
Free Cash Flow$60M$178M$141M$17M$1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms